Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome

Journal of Drugs in Dermatology

Volumn 11, Issue 11, 2012, Pages 1364-1365

  Wolfe, Christopher M ^a   Green, W Harris ^b   Hatfield, H Keith ^b   Cognetta, Armand B ^b  

^a LAKE ERIE COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^b Dermatology Associates of Tallahassee   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; ANTIHISTAMINIC AGENT; CALCIUM; DOXYCYCLINE; MULTIVITAMIN; VISMODEGIB; VITAMIN B GROUP;

ADULT; APPLICATION SITE URTICARIA; ARTICLE; BASAL CELL NEVUS SYNDROME; CASE REPORT; DRUG WITHDRAWAL; FACE; FEMALE; HUMAN; LIMB; PHOTODYNAMIC THERAPY; RED LIGHT; ROSACEA; TREATMENT OUTCOME; TRUNK;

EID: 84870203084     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Lo Muzio L. Nevoid basal cell carcinoma syndrome (Gorlin syndrome). Orphanet J Rare Dis. 2008;3:32.
2. Braathen LR, Szeimies RM, Basset-Seguin N, et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol. 2007;56(1):125-143. (Pubitemid 44969292)
3. Horn M, Wolf P, Wulf HC, et al. Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol. 2003;149(6):1242-1249. (Pubitemid 38058101)
4. Vinciullo C, Elliott T, Francis D, et al. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma. Br J Dermatol. 2005;152(4):765-772. (Pubitemid 40571312)
5. Szeimies RM, Ibbotson S, Murrell DF, et al. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up. J Eur Acad Dermatol Venereol. 2008;22(11):1302-1311.
6. Wulf HC, Philipsen P. Allergic contact dermatitis to 5-aminolaevulinic acid methylester but not to 5-aminolaevulinic acid after photodynamic therapy. Br J Dermatol. 2004;150(1):143-145. (Pubitemid 38234020)
7. Brooke RC, Sinha A, Sidhu MK, et al. Histamine is released following aminolevulinic acid-photodynamic therapy of human skin and mediates an aminolevulinic acid dose-related immediate inflammatory response. J Invest Dermatol. 2006;126(10):2296-2301. (Pubitemid 44413177)
8. Kaae J, Philipsen PA, Haedersdal M, Wulf HC. Immediate whealing urticaria in red light exposed areas during photodynamic therapy. Acta Derm Venereol. 2008;88(5):480-483.
9. U.S. Food and Drug Administration Web site. Metvixia (methyl aminolevulinate) prescribing information. June 2008. http://www.accessdata.fda. gov/drugsatfda-docs/label/2008/021415s003lbl.pdf. Accessed January 20, 2012.
10. Bjellerup M, Ljunggren B. Double blind cross-over studies on phototoxicity to three tetracycline derivatives in human volunteers. Photodermatol. 1987;4(6):281-287. (Pubitemid 18025094)
11. Johnson BE, Ferguson J. Drug and chemical photosensitivity. Semin Dermatol. 1990;9(1):39-46. (Pubitemid 20171870)